Colinz Laboratories Ltd files non‑applicability statement under SEBI LODR Reg 32 for Q2 2026

What Colinz Laboratories Ltd announced

On 3 July 2026, Colinz Laboratories Ltd (BSE: 531210) submitted a Declaration of Non‑Applicability of Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statement covers the quarter ended 30 June 2026 and confirms that the company did not undertake any public issue, rights issue, preferential issue or Qualified Institutional Placement (QIP) during that period.

Regulation 32 – purpose and scope

Regulation 32 mandates listed entities to disclose the use of proceeds from any capital‑raising instrument such as a public issue, rights issue, preferential issue or QIP. If a company does not raise capital through these instruments in a reporting quarter, it must file a Statement of Deviation or Variation stating the non‑applicability. This ensures transparency for investors and regulators regarding how the company finances its operations.

Details of the declaration

• Filing date: 3 July 2026 (07:19 UTC)
• Reporting period: Quarter ended 30 June 2026 (referred to as “June‑26” in the filing).
• Content: A brief letter from a director stating that the required disclosure under Regulation 32 is attached and that there were no applicable capital‑raising events.
• Document link: The PDF is hosted on the BSE portal (URL provided in the filing).
• Implication: Since no issue was made, there is no allocation of proceeds to be disclosed, and the existing share capital remains unchanged.

Key facts at a glance

Why this matters for investors

The declaration confirms that no dilution of shareholding occurred in the quarter, preserving the equity position of existing shareholders. It also demonstrates the company's adherence to SEBI’s disclosure norms, which is a positive compliance signal. For investors tracking capital‑raising activity, the filing indicates that Colinz Laboratories did not seek external funding through listed instruments during the period, implying that any operational financing came from internal cash flows or existing credit facilities.

Conclusion

Colinz Laboratories Ltd has fulfilled its regulatory obligation by filing a non‑applicability statement under SEBI LODR Regulation 32 for the quarter ended 30 June 2026. The filing confirms that the company did not issue any new securities, leaving its share capital unchanged. No further action or shareholder approval is required at this stage.